CLOCK.BIO
LIVE

Serial Number

79430723

Owner

Clock Bio Limited

Attorney

Bridget Hoy

Filing Date

Mar 28, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CLOCK.BIO Trademark

Serial Number: 79430723

CLOCK.BIO is a trademark filed by Clock Bio Limited on March 28, 2025. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Clock Bio Limited (2 trademarks)

C/o PEM,

Entity Type: 98

Trademark Details

Filing Date

March 28, 2025

Registration Date

Not Registered

Goods & Services

Custom manufacture of biopharmaceuticals; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media, chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells, semi-processed natural proteins for manufacturing food, proteins for use in the manufacture of food products, proteins for use in recombinant DNA technology, cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and/or veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing and screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents, magnetic cell separation equipment, dietary supplements, protein supplements and nutrition supplements.

Cell therapeutics for medical, pharmaceutical, clinical and veterinary use; genetically or otherwise modified cells for medical, medical diagnostic, pharmaceutical, clinical and veterinary use; cells which are propagated, cultivated and expanded in bioreactors, all being for medical, medical diagnostic, pharmaceutical, clinical and veterinary use; cells for the purpose of tissue regeneration, all being for medical, pharmaceutical, clinical and veterinary use; living cells for medical use; cells for medical use; biological preparations for medical use for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, renal, oncological, hepatological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, genitourinary, hormonal, dermatological, infectious, and immune system related diseases and disorders; diagnostic preparations for medical and veterinary purposes; pharmaceutical cell preparations for drug screening; pharmaceutical cell preparations for genetic testing and screening; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells for medical, pharmaceutical, clinical and veterinary, and diagnostic use; tissue culture media for use in tissue culture for medical, pharmaceutical, clinical and veterinary, and diagnostic use; cytokines, antibodies, and reagents for medical, medical research and diagnostic use; tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay and manipulation of cells; cell separation reagents for medical, medical diagnostic, pharmaceutical, clinical and veterinary purposes; dietary supplements; protein supplements; nutrition supplements.

Non-medicated cosmetics and toiletry preparations; cosmetics and cosmetic preparations; skin care preparations, not for medical purposes.

Biotechnology research; biotechnology testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; stem cell research; synthetic biology services, namely biological research; stem cell biology services, namely biological research and analysis; scientific laboratory services relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testing and screening; research and development in relation to drug screening; cell separation technology services for scientific, research, clinical, medical, and manufacturing purposes; cell separation research services; consultancy relating to biotechnology; consultancy relating to drug screening for scientific research purposes; consultancy relating to genetic screening for scientific research purposes; consultancy relating to cell therapy for scientific research purposes; laboratory research in the field of pharmaceutical and drug discovery; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions; development and testing of computing methods, algorithms and software for medical, clinical, research and biomanufacturing purposes.

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
May 1, 2026 GNFN
FINAL REFUSAL E-MAILED
May 1, 2026 GNFR
FINAL REFUSAL WRITTEN
May 1, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 20, 2026 TROA
REFUSAL PROCESSED BY IB
Nov 7, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 18, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 18, 2025 RFRR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 17, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 17, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 17, 2025 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 3, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 2, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 26, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 25, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 21, 2025 REPR